Novel Insights on Ferroptosis Modulation as Potential Strategy for Cancer Treatment: When Nature Kills

Valeria Consoli1, Antonino Nicolò Fallica1, Valeria Sorrenti1,2

  • 1Department of Drug and Health Sciences, University of Catania, Catania, Italy.

Insights

Natural compounds show promise for cancer therapy by inducing ferroptosis, a unique cell death pathway. This review explores ferroptosis mechanisms and natural compounds, offering insights for future anticancer drug discovery.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Oncology

Background:

  • Cancer development involves complex mechanisms challenging current therapies.
  • Ferroptosis, a distinct form of programmed cell death, and its pathways offer new therapeutic targets.
  • Natural compounds are increasingly recognized for their ferroptosis-inducing potential.

Purpose of the Study:

  • To review key biochemical pathways in ferroptosis execution.
  • To analyze novel findings on ferroptosis hallmarks and mechanisms.
  • To explore natural compounds with ferroptosis-inducing properties for anticancer drug discovery.

Main Methods:

  • Literature review of ferroptosis execution pathways.
  • Analysis of canonical and non-canonical ferroptosis hallmarks.
  • Classification of natural compounds based on chemical structure and ferroptosis-inducing mechanisms.

Main Results:

  • Detailed examination of ferroptosis biochemical pathways and molecular mechanisms.
  • Identification and classification of natural compounds exhibiting ferroptosis-inducing activity.
  • Evidence of *in vitro* and *in vivo* efficacy for select natural compounds.

Conclusions:

  • Natural compounds represent a promising source for developing novel ferroptosis inducers.
  • Understanding ferroptosis pathways is crucial for identifying effective anticancer agents.
  • This review provides a foundation for future drug discovery targeting ferroptosis in cancer therapy.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.7K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.8K
Necrosis01:16

Necrosis

Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.7K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.1K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.9K